BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23582917)

  • 1. Neuroendocrine tumours of the small intestine.
    Strosberg J
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):755-73. PubMed ID: 23582917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
    Ardill JE; Johnston BT; McCance DR; Eatock M
    Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AACE/ACE disease state clinical review: diagnosis and management of midgut carcinoids.
    Liu EH; Solorzano CC; Katznelson L; Vinik AI; Wong R; Randolph G
    Endocr Pract; 2015 May; 21(5):534-545. PubMed ID: 25962092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of midgut carcinoids.
    Akerström G; Hellman P; Hessman O; Osmak L
    J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management.
    Modlin IM; Moss SF; Oberg K; Padbury R; Hicks RJ; Gustafsson BI; Wright NA; Kidd M
    Med J Aust; 2010 Jul; 193(1):46-52. PubMed ID: 20618115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on medical treatment of small intestinal neuroendocrine tumors.
    Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Small Bowel Neuroendocrine Tumors.
    Scott AT; Howe JR
    Surg Oncol Clin N Am; 2020 Apr; 29(2):223-241. PubMed ID: 32151357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving treatment strategies for management of carcinoid tumors.
    Strosberg J
    Curr Treat Options Oncol; 2013 Sep; 14(3):374-88. PubMed ID: 23892588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children.
    Johnson PR
    Semin Pediatr Surg; 2014 Apr; 23(2):91-5. PubMed ID: 24931354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotherapies for GEP-NETs.
    Öberg K
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):833-41. PubMed ID: 23582922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum.
    Blažević A; Hofland J; Hofland LJ; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2018 Mar; 25(3):R115-R130. PubMed ID: 29233841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts.
    Bonds M; Rocha FG
    Surg Clin North Am; 2020 Jun; 100(3):635-648. PubMed ID: 32402306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.
    Strosberg JR; Cheema A; Kvols LK
    Cancer Control; 2011 Apr; 18(2):127-37. PubMed ID: 21451455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoid tumors].
    Pregun I; Bodoky G; Rácz K; Tulassay Z
    Orv Hetil; 2010 Nov; 151(46):1885-94. PubMed ID: 21044939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small bowel neuroendocrine tumours - casting the net wide.
    Chetcuti Zammit S; Sidhu R
    Curr Opin Gastroenterol; 2023 May; 39(3):200-210. PubMed ID: 37144538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical scenario 2: Exploring treatment options for patients with symptomatic, progressive GEP-NETs.
    Pape UF
    Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):20-2. PubMed ID: 25768106
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carcinoid tumors of the intestines: developments in the Netherlands for diagnosis and palliative treatment].
    Taal BG; Hoefnagel C; Boot H; de Jong D; Rutgers M
    Ned Tijdschr Geneeskd; 1999 Feb; 143(9):445-51. PubMed ID: 10221120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.